Consensus Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
0.8172 ^USD	-3.18%		-1.19%	-30.75%

Apr. 26	Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	MT
Apr. 26	Vincerx Pharma Prices Public Offering of Shares, Warrants	MT

Evolution of the average Target Price on Vincerx Pharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e91255e07.SPgfPP6StC7_anlet7cVPQKsxAscFSqhvm_MnEEAq6M.Gr4nCovq4kqUWE4b2udkBTT18WhpcBiU8iGI7hBi4pR4vEp1k9DxR41SDg~3e27cd72bf5603becd55c64ddee993ee

Analyst Recommendations on Vincerx Pharma, Inc.

Chardan Trims Price Target on Vincerx Pharma to $3 From $4, Keeps Buy Rating	22-11-17	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $5 From $6, Keeps Outperform Rating	22-08-12	MT
Cantor Fitzgerald Adjusts Vincerx Pharma's Price Target to $8 From $22, Reiterates Overweight Rating	22-06-08	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 as it Shifts VIP152 Launch to 2026 From 2024 Reiterates Buy Rating	22-06-07	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $6 From $19, Keeps Outperform Rating	22-06-07	MT
B. Riley Adjusts Vincerx Pharma Price Target to $6 From $12, Maintains Buy Rating	22-06-07	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 on Adjusted VIP152 Estimates, Reiterates Buy Rating	22-06-07	MT
Chardan Lowers Vincerx Pharma's Price Target to $11 From $14, Buy Rating Kept	22-05-13	MT
B. Riley Lowers Vincerx Pharma's Price Target to $12 from $26, Says May Need to Raise Additional Capital Under Unfavorable Conditions; Keeps Buy Rating	22-04-12	MT
SVB Leerink Adjusts Vincerx Pharma's Price Target to $20 from $24, Keeps Outperform Rating	22-03-30	MT
HC Wainwright Adjusts Vincerx Pharma's Price Target to $28 From $25, Reiterates Buy Rating	22-03-30	MT
HC Wainwright Starts Vincerx Pharma at Buy With $25 Price Target	22-01-14	MT
Cantor Fitzgerald Starts Vincerx Pharma at Overweight With $25 Price Target	21-12-23	MT
SVB Leerink Starts Vincerx Pharma at Outperform with $24 Price Target	21-11-01	MT
VINCERX PHARMA : Laidlaw & Co. Starts Vincerx Pharma at Buy with $30 Price Target	21-09-13	MT
VINCERX PHARMA : B. Riley Starts Vincerx Pharma at Buy with $26 PT, Says Shares Offer 'Attractive' Entry Point Ahead of VIP152 Clinical Updates; Keeps Buy Rating	21-08-25	MT
VINCERX PHARMA : Chardan Adjusts Price Target on Vincerx to $30 From $33, Citing 'Forward OpEx Estimates, Recent Dilution;' Buy Rating Kept	21-08-13	MT
VINCERX PHARMA : Chardan Starts Vincera Pharma at Buy With $33 Price Target	21-01-06	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8172 USD

Average target price

9 USD

Spread / Average Target

+1,001.32%

High Price Target

10 USD

Spread / Highest target

+1,123.69%

Low Price Target

8 USD

Spread / Lowest Target

+878.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vincerx Pharma, Inc.

Chardan Research
SVB Securities LLC
Cantor Fitzgerald
B. Riley
HC Wainwright
SVB Leerink
Laidlaw & Co.
Chardan

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar